Skip to main content
S 823 110th Congress Senate Health AIDS (Disease) Centers for Disease Control and Prevention (CDC) Clinical trials Commerce Congress Congress and foreign policy Congressional reporting requirements Department of Health and Human Services Developing countries Drug industry Drugs Economics and Public Finance Executive reorganization Federal aid to research Government Operations and Politics Government and business Government procurement Human behavior Human immunodeficiency viruses

Microbicide Development Act

Introduced: March 8, 2007 See on congress.gov
This bill died when the 110th Congress ended
It never became law before the 110th Congress (2007–2008) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Mar 8, 2007
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Mar 8, 2007
Sponsor introductory remarks on measure. (CR S2919-2920)
Mar 8, 2007
Introduced in Senate
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Plain-English summary Congressional Research Service

Microbicide Development Act - Amends the Public Health Service Act to require the Director of the Office of AIDS Research to: (1) expedite the implementation of the federal strategic plan for the conduct and support of microbicide research and development; and (2) expand, intensify, and coordinate all activities with respect to research and development of microbicides to prevent the transmission of HIV and other sexually transmitted diseases.

Requires the Director of the National Institute of Allergy and Infectious Diseases to: (1) establish within the Division of AIDS an organizational branch to carry out microbicide research and development; and (2) assign priority to ensuring adequate funding and support for the Microbicide Trials Network and other programs for supporting microbicides clinical trials.

Requires the Director of the Centers for Disease Control and Prevention (CDC) to fully implement the CDC's microbicide agenda to support microbicide research and development.

Directs the head of the Office of HIV/AIDS of the U.S. Agency for International Development (USAID) to develop and implement a program to support the development of microbicides products for the prevention of the transmission of HIV/AIDS and other diseases, and facilitate wide-scale availability of such products.

Requires the Secretary of State to report to Congress on advance market commitments of microbicides to prevent HIV infection as a means of creating private sector investment incentives.

What's happening now March 8, 2007

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

 Related & companion bills 1
 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 1
Cite this page click to expand
APA
U.S. Congress. (2026). S. 823: Microbicide Development Act. 110th Congress. Open America. https://openamerica.io/bill/110-S-823/
MLA
"S. 823: Microbicide Development Act." 110th Congress, 2026, Open America, https://openamerica.io/bill/110-S-823/.
Bluebook (legal)
S. 823, 110th Cong. (2026), https://openamerica.io/bill/110-S-823/.
Markdown link
[S. 823: Microbicide Development Act](https://openamerica.io/bill/110-S-823/)
Report a problem